Description
PRINCIPIO ACTIVO: ALVERINA - SIMETICONA
PRINCIPIO ACTIVO: LIDAMIDINA CLORHIDRATO
Factor VIII recombinante humano 2000 UI
principalmente al inicio del tratamiento
DALAFAR CAP. 300 MG. CAJA C/16 OTILONIO BROMURO PRINCIPIO ACTIVO: ALVERINA - SIMETICONASUSTANCIA: DALAFAR CAP. 300 MG. CAJA C 16 FABRICANTE: SYNTHON
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
